DALLAS: A type 2 diabetes drug could prevent Alzheimer’s disease from developing, new research has suggested.
A small study looking at Victoza (liraglutide), an injectable drug that lowers blood glucose levels, showed it offers protection from the brain disease.
A total of 38 people with Alzheimer’s disease took part in the trial, of which the findings have just been published. Half the group injected the drug every day for six months.
Researchers from the Aarhus University in Denmark said that the drug prevented a reduction in the amount of energy being used by the brain. The group taking the placebo showed a significant decline in brain energy use over the same period of time.
Professor Jorgen Rungby, who led the initial study, said: “This is a significant step. We now have a drug that appears to have some kind of effect on how the brain works in Alzheimer’s…